Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Ovarian Epithelial × Doxorubicin × 90 days × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 21 Burkitt Lymphoma 12 Breast Neoplasms 11 Neoplasms 10 Lymphoma, Follicular 10 Lymphoma 9 Triple Negative Breast Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Sarcoma 7 Ovarian Neoplasms 6 Hodgkin Disease 6 Endometrial Neoplasms 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, B-Cell 5 Sarcoma, Ewing 4 Recurrence 4 Osteosarcoma 4 Neuroblastoma 4 Neoplasm Metastasis 4 Lymphoma, Non-Hodgkin 4 Lymphoma, Mantle-Cell 4 Liposarcoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Fallopian Tube Neoplasms 4 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Biphenotypic, Acute 3 Leiomyosarcoma 3 Inflammatory Breast Neoplasms 3 Ganglioneuroblastoma 3 Urinary Bladder Neoplasms 2

Interventions

Paclitaxel 5 Bevacizumab 5 Carboplatin 4 mirvetuximab soravtansine 3 pembrolizumab 2 olaparib 2 liposomal doxorubicin 2 Hyperthermic Intraperitoneal Chemotherapy 2 trastuzumab deruxtecan 1 rucaparib 1 ribociclib 1 pegfilgrastim 1 palbociclib 1 niraparib 1 isoquercitrin 1 fludarabine phosphate 1 fludarabine 1 cemiplimab 1 Topotecan 1 Saline Solution 1 Preoperative Exercise 1 Platinum 1 Pharmaceutical Preparations 1 Nutrition Assessment 1 Nivolumab 1 Neoadjuvant Therapy 1 Injections 1 Immunotherapy, Adoptive 1 Glucose 1 GEN-1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡